Inspire Medical Systems CFO Rick Buchholz to step down at year-end 2025, company reaffirms full-year guidance.

Inspire Medical Systems' CFO Rick Buchholz will step down at the end of 2025 after 11 years with the company. Buchholz will continue in a financial advisory role until late February, and Inspire is searching for a new CFO. RBC Capital Markets analysts note that the news is unexpected but does not change their views on the company, which has reaffirmed its full-year financial guidance.

Inspire Medical Systems (NYSE: INSP) has announced that its Chief Financial Officer, Rick Buchholz, will be stepping down from his current position with the company, effective December 31, 2025. Buchholz will continue in a financial advisory role until February 28, 2026, to ensure a smooth transition. The company has initiated an active search for Buchholz's replacement.

Buchholz has been with Inspire Medical Systems for over 11 years. His departure comes at a time when the company has reaffirmed its previously issued guidance for full-year 2025. The guidance includes revenue of $900 million to $910 million, a gross margin of 84% to 86%, and diluted net income per share of $0.40 to $0.50 [1].

RBC Capital Markets analysts have noted that the news is unexpected but does not alter their views on the company. Inspire Medical Systems continues to operate under its established financial guidance, suggesting a stable outlook despite the leadership change [2].

Inspire Medical Systems is a leading provider of sleep apnea solutions, and Buchholz's departure marks a significant shift in its financial leadership. The company has been proactive in managing this transition, indicating a commitment to continuity and stability [3].

References:
[1] https://seekingalpha.com/news/4489330-inspire-medical-systems-cfo-departs
[2] https://www.bizjournals.com/twincities/news/2025/08/27/inspire-medical-systems-cfo-stepping-down.html
[3] https://www.marketwatch.com/story/inspire-medical-systems-cfo-to-resign-9dae349b